 |
| Non-Invasive Biosensors Market |
The global Non-Invasive Biosensors Market is estimated to be valued at US$ 29.84 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Non-invasive biosensors are medical devices used for monitoring various
physiological parameters without drawing blood or breaching the skin. They are
widely used for monitoring blood glucose, heart rate, blood pressure etc. These
accurate and easy-to-use devices provide real-time health insights to users.
Market key trends:
Miniaturization of sensors is one of the major trends observed in the
non-invasive biosensors market. The increasing demand for compact, inexpensive
and user-friendly medical devices has accelerated technological advancements in
the miniaturization of biosensors. Miniaturized sensors integrated with
wearable technologies like smartwatches and fitness bands are gaining
popularity as they enable continuous monitoring of critical health parameters
without hindering daily activities. This has significantly boosted the adoption
of non-invasive biosensors across various application areas.
Segment Analysis
The global non-invasive biosensors market is segmented into wearable biosensors
and non-wearable biosensors. The wearable biosensors segment dominates the
market and is expected to witness high growth during the forecast period. The
growth of this segment can be attributed to the increasing adoption of wearable
devices for health monitoring and fitness tracking. Advantages of wearable
biosensors such as continuous monitoring, real-time data acquisition, and
portability make them popular across various end-use industries.
Key Takeaways
Market size
The global Non-Invasive
Biosensors Market Share is expected to witness high growth, exhibiting
a CAGR of 7.9% over the forecast
period, due to the increasing prevalence of chronic diseases and growing
geriatric population. Non-invasive biosensors help in continuous monitoring of
various health parameters in patients.
Regional analysis
North America dominates the global non-invasive biosensors market owing to the
rising healthcare expenditure and presence of major players in the US. However,
Asia Pacific is expected to exhibit the highest CAGR during the forecast period
due to increasing healthcare awareness, disposable income, and government
initiatives to promote digital healthcare in countries such as India and China.
Key players
Key players operating in the non-invasive biosensors market are Akers
Biosciences, Inc., Philips Healthcare, Abbott Laboratories, GE Healthcare,
Nemaura Medical, Inc., Integrity Applications Inc., OrSense, MediWise Ltd., and
Medtronic Plc. These players are focusing on new product launches and strategic
collaborations to strengthen their market position. For instance, in 2022, Medtronic
Plc launched the Minimally Invasive Hugo ROBotic-Arm Assist System to expand
its surgical robotics portfolio.
For more
insights, Read- https://www.ukwebwire.com/non-invasive-biosensors-market-trends-size-and-share-analysis/
0 Comments